Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
1988-11-16
pubmed:abstractText
The immunohistochemical reactivity of 38 mesotheliomas and 44 adeno-carcinomas or large cell carcinomas of the lung with monoclonal antibodies (MAb) B72.3 and Leu M1 was compared with their reactivity with the routine histochemic stains periodic acid-Schiff with diastase digestion (PAS-D) and alcian blue +/- hyaluronidase. Both MAbs reacted selectively with carcinomas when a positive test was set at greater than or equal to 10% reactive tumor cells. However, MAb B72.3 reacted with significantly more of the carcinomas (86%, chi-square test, P less than 0.01) and bound to a greater percentage of tumor cells (47 +/- 28%; mean +/- SD, t-test, P less than 0.001) than Leu M1 (57% and 25 +/- 28%, respectively). The similar reactivities of surgically resected tumor specimens and post mortem tissues with both antibodies confirmed antigen stability and suggested broad clinical utility. PAS-D stained 61% of the carcinomas. Using the markers for carcinomas (PAS-D, B72.3, and Leu M1), the tumors were classified into the correct group in 80 of 82 (98%) cases (95% confidence level: greater than 92% accuracy). The alcian blue stain was useful to confirm a diagnosis of dimorphic or epithelial mesothelioma (48% were positive).
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/2845790-152898, http://linkedlifedata.com/resource/pubmed/commentcorrection/2845790-2414203, http://linkedlifedata.com/resource/pubmed/commentcorrection/2845790-2418688, http://linkedlifedata.com/resource/pubmed/commentcorrection/2845790-2418692, http://linkedlifedata.com/resource/pubmed/commentcorrection/2845790-2422108, http://linkedlifedata.com/resource/pubmed/commentcorrection/2845790-2422942, http://linkedlifedata.com/resource/pubmed/commentcorrection/2845790-2434407, http://linkedlifedata.com/resource/pubmed/commentcorrection/2845790-2435259, http://linkedlifedata.com/resource/pubmed/commentcorrection/2845790-2438392, http://linkedlifedata.com/resource/pubmed/commentcorrection/2845790-2438954, http://linkedlifedata.com/resource/pubmed/commentcorrection/2845790-2441518, http://linkedlifedata.com/resource/pubmed/commentcorrection/2845790-2445194, http://linkedlifedata.com/resource/pubmed/commentcorrection/2845790-2579718, http://linkedlifedata.com/resource/pubmed/commentcorrection/2845790-2982715, http://linkedlifedata.com/resource/pubmed/commentcorrection/2845790-3022920, http://linkedlifedata.com/resource/pubmed/commentcorrection/2845790-302896, http://linkedlifedata.com/resource/pubmed/commentcorrection/2845790-3085523, http://linkedlifedata.com/resource/pubmed/commentcorrection/2845790-3092632, http://linkedlifedata.com/resource/pubmed/commentcorrection/2845790-3168714, http://linkedlifedata.com/resource/pubmed/commentcorrection/2845790-3653068, http://linkedlifedata.com/resource/pubmed/commentcorrection/2845790-3717302, http://linkedlifedata.com/resource/pubmed/commentcorrection/2845790-3887932, http://linkedlifedata.com/resource/pubmed/commentcorrection/2845790-3940648, http://linkedlifedata.com/resource/pubmed/commentcorrection/2845790-4122202, http://linkedlifedata.com/resource/pubmed/commentcorrection/2845790-6179666, http://linkedlifedata.com/resource/pubmed/commentcorrection/2845790-6186071, http://linkedlifedata.com/resource/pubmed/commentcorrection/2845790-6201076, http://linkedlifedata.com/resource/pubmed/commentcorrection/2845790-6287872, http://linkedlifedata.com/resource/pubmed/commentcorrection/2845790-6588749, http://linkedlifedata.com/resource/pubmed/commentcorrection/2845790-6741873, http://linkedlifedata.com/resource/pubmed/commentcorrection/2845790-6789331, http://linkedlifedata.com/resource/pubmed/commentcorrection/2845790-7435773
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0002-9440
pubmed:author
pubmed:issnType
Print
pubmed:volume
133
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
30-8
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1988
pubmed:articleTitle
Differentiation of adenocarcinoma of the lung from mesothelioma. Periodic acid-Schiff, monoclonal antibodies B72.3, and Leu M1.
pubmed:affiliation
Department of Pathology, University of California, San Francisco 94143-0506.
pubmed:publicationType
Journal Article